Effect of donepezil on reversal learning in a touch screen-based operant task

Behavioural Pharmacology

Volumn 20, Issue 7, 2009, Pages 653-656

  Chen, Woei Shin ^a,b   Wong, Fong Kuan ^a   Chapman, Paul F ^a   Pemberton, Darrel J ^a,c  

^a Singapore Research Centre   (Singapore)

^b Helios Building   (Singapore)

^c Neurosciences Division Johnson and Johnson PRF   (Belgium)

Author keywords

Donepezil; Operant task; Rat; Reversal learning; Touch screen

Indexed keywords

ACETYLCHOLINESTERASE; DONEPEZIL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATION LEARNING; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG EFFECT; LEARNING; MALE; MEMORY; NEWBORN; NONHUMAN; RAT; REWARD; TASK PERFORMANCE;

ANIMALS; CHOLINESTERASE INHIBITORS; COMPUTER PERIPHERALS; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; INDANS; MALE; PIPERIDINES; RATS; RATS, INBRED STRAINS; REVERSAL LEARNING;

EID: 70349671770     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32832ec5bc     Document Type: Article

References (22)

1. Bussey TJ, Padain TL, Skillings EA,Winters BD, Morton AJ, Saksida LM (2008). The touchscreen cognitive testing method for rodents: how to get the best out of your rat. Learn Mem 15:516-523.
2. Chung YC, Lee CR, Park TW, Yang KH, Kim KW (2007). Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial. World J Biol Psychiatry 10:1-7.
3. Clark L, Cools R, Robbins TW (2004). The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn 55:41-53.
4. Cools R, Clark L, Owen AM, Robbins TW (2002). Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci 22:4563-4567.
5. Hernandez CM, Gearhart DA, Parikh V, Hohnadel EJ, Davis LW, Middlemore ML, et al. (2006). Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats. J Pharmacol Exp Ther 316:679-694.
6. Kohler CG, Martin EA, Kujawski E, BilkerW, Gur RE, Gur RC (2007). No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. Cognit Neuropsychiatry 12:412-421.
7. Lee BJ, Lee JG, Kim YH (2007). A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia. J Psychopharmacol 21:421-427.
8. Lleó A, Greenberg SM, Growdon JH (2006). Current pharmacotherapy for Alzheimer's disease. Annu Rev Med 57:513-533.
9. McKirdy J, Sussmann JED, Hall J, Lawrie SM, Johnstone EC, McIntosh AM (2008). Set shifting and reversal learning in patients with bipolar disorder or schizophrenia. Psychol Med 24:1-5. doi:10.1017/S0033291708004935.
10. Mumenthaler MS, Yesavage JA, Taylor JL, O'Hara R, Friedman L, Lee H, Kraemer HC (2003). Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects. Neuropsychopharmacol 28:1366-1373.
11. Peuskens J, Demily C, Thibaut F (2005). Treatment of cognitive dysfunction in schizophrenia. Clin Ther 27:S25-S37.
12. Ragozzino ME, Jih J, Tzavos A (2002). Involvement of dorsomedial striatum in behavioural flexibility: role of muscurinic cholinergic receptors. Brain Res 953:205-214.
13. Ragozzino ME, Mohler EG, Prior M, Palencia CA, Rozman S (2008). Acetylcholine activity in selective striatal regions supports behavioural flexibility. Neurobiol Learn Mem 91:13-22. doi: 10.1016/j.nlm2008.09.008.
14. Robbins TW (2005). Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 493:140-146.
15. Rogers DC, Hagan JJ (2001). 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacol (Berl) 158:114-119.
16. Rupniak NM, Tye SJ, Field MJ (1997). Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys. Psychopharmacol (Berl) 131:406-410.
17. Seltzer B (2007). Donepezil: an update. Expert Opin Pharmacother 8: 1011-1023.
18. Spowart-Manning L, van der Staay FJ (2005). Spatial discrimination deficits by excitotoxic lesions in the Morris water escape task. Behav Brain Res 156:269-276.
19. Stip E, Sepehry AA, Chouinard S (2007). Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2. Clin Neuropharmacol 30:218-229. (Pubitemid 47356719)
20. Van Dam D, Abramowski D, Staufenbiel M, De Deyn PP (2005). Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. Psychopharmacol (Berl) 180:177-190.
21. Waltz JA, Gold JM (2007). Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophrenia Res 93:296-303.
22. Yesavage JA, Mumenthaler MS, Taylor JL, Friedman L, O'Hara R, Sheikh J, et al. (2002). Donepezil and flight simulator performance: effects on retention of complex skills. Neurology 59:123-125.